Related news
Discover more stories about Mitacs — and the game-changing innovations driven by students and postdocs.
By Felisha Adam
McGill University’s Prisca Bustamante was recoognized by the 2021 Mitacs Awards for Outstanding Innovation — PhD for developing the world’s first non-invasive blood screening test for uveal melanoma, the most common eye cancer found in adults. Her novel test is currently being used in a clinical study at the McGill Academic Eye Centre and is expected to have global impact. She says the non-invasive blood screening test will be easily accessible and save lives by detecting cancer earlier. “Our test is minimally invasive, it is a blood collection, so it’s accessible,” she said. “There are no side effects, a patient can go to an eye clinic, have their blood collected – the blood is going to be analyzed in the lab – and then go home. Without any side effects,” explained Bustamante.
Discover more stories about Mitacs — and the game-changing innovations driven by students and postdocs.
Award Ceremony to Take Place November 22 Ottawa, ON — A breakthrough treatment for prostate cancer, an AI system that better detects heart disease, a revolutionary technology to clean up dangerous toxins, and a first-of-its-kind app to improve the lives of people with disabilities, are just some of the groundbreaking Canadian innovations that are being […]
Read More
By Angie Seth Sara Child is a professor in Indigenous Education at North Island College and is leading the research effort to recover Kwak’wala with her organization Sanyakola Foundation. Establish in 2017, the not-for-profit is currently focusing on Indigenous language revitalization in consultation with Kwakwaka’wakw elders. The project is one of dozens of Canadian research projects highlighted in a […]
Read More
NURA Medical’s breakthrough smart arm bracelet technology is changing the way in which emergency room clinicians work with children. As a part of Their World, Our Future, an Innovation Trends video series by Mitacs, NURA Medical’s invention aids the administration of life-saving medicine to kids, all while increasing efficiency and efficacy. Read more…
Read MoreMitacs is funded by the Government of Canada, the Government of Alberta, the Government of British Columbia, Research Manitoba, the Government of New Brunswick, the Government of Newfoundland and Labrador, the Government of Nova Scotia, the Government of Ontario, Innovation PEI, the Government of Quebec, the Government of Saskatchewan, and the Government of Yukon.